Healios K.K. Healios K.K.

Healios K.K.

4593

Rank in Stocks #16766
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011,... Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced pluripotent stem cell (iPSC)-derived regenerative medicines aimed at treating age-related macular degeneration. Another iPSC-based therapy, HLCL041, is being developed for metabolic liver disease. Furthermore, Healios is progressing HLCM051, a regenerative treatment designed for ischemic stroke and acute respiratory distress syndrome, alongside HLCN061 for solid tumor indications. The company also maintains a joint research partnership with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies to combat mesothelioma. Healios K.K. adopted its current name in September 2013, having previously operated under the name Retina Institute Japan, K.K.
Share Price
$1.43
Last synced: 2026-11-13
Market Cap
$193.25M
Change (1 day)
-3.51%
Change (1 year)
-50.84%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Healios K.K. (4593)
Operating Margin as of November 2026 TTM: -10,514.89%
According to Healios K.K.'s latest financial reports, its current operating margin (TTM) is -10,514.89%. At the end of 2025 the company had an operating margin of -3,272.12%.
Operating Margin history for Healios K.K. from 2014 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -10,514.89% 221.35%
2025 -3,272.12% 531.43%
2024 -518.21% -81.44%
2023 -2,792.56% -51.47%
2022 -5,754.44% -56.18%
2021 -13,131.71% -15.26%
2020 -15,496.30% 222.91%
2019 -4,798.88% 0.00%
2018 0.00% -100.00%
2017 -8,487.70% 87.88%
2016 -4,517.60% 318.21%
2015 -1,080.22% 432.21%
2014 -202.97% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -99.98%
US
33.87% -100.00%
US
-116.04% -99.99%
US
25.57% -100.00%
AU
31.23% -100.00%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Healios K.K.'s operating margin

What is Healios K.K.'s operating margin?

Healios K.K.'s operating margin is -10,514.89%, as of Nov 2026.

What was Healios K.K.'s operating margin in 2025?

In 2025, Healios K.K.'s operating margin was -3,272.12%, compared with -518.21% in 2024.

How has Healios K.K.'s operating margin changed since 2020?

From 2020 to 2025, Healios K.K.'s operating margin was highest in 2024 (-518.21%) and lowest in 2020 (-15,496.30%).

How does Healios K.K.'s operating margin compare with similar companies?

Healios K.K.'s operating margin (-10,514.89%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.